- Home
- INDB vs AMLX Comparison
INDB vs AMLX Comparison
Compare INDB & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDB | AMLX |
|---|---|---|
| Founded | 1907 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INDB | AMLX |
|---|---|---|
| Price | $83.81 | $27.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $93.43 | $43.00 |
| AVG Volume (30 Days) | 425.8K | ★ 1.2M |
| Earning Date | 10-15-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ 3.33 | N/A |
| Revenue | N/A | ★ $380,786,000.00 |
| Revenue This Year | $20.55 | N/A |
| Revenue Next Year | $4.97 | N/A |
| P/E Ratio | $25.02 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $65.45 | $10.83 |
| 52 Week High | $87.50 | $41.14 |
Technical Indicators
Market Signals| Indicator | INDB | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 65.17 | 42.96 |
| Support Level | $82.49 | $26.12 |
| Resistance Level | $84.45 | $28.60 |
| Average True Range (ATR) | 1.64 | 1.32 |
| MACD | 0.83 | 0.15 |
| Stochastic Oscillator | 96.84 | 32.58 |
Price Performance
Historical ComparisonAbout INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.